{"id":"W4237577048","doi":"10.1200/jco.2015.33.15_suppl.e13528","title":"Development of a proposed biosimilar product based on the demonstration of physicochemical, pharmacologic and clinical similarity to filgrastim.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Filgrastim; Biosimilar; Medicine; Clinical endpoint; Pharmacology; Clinical trial; Oncology; Internal medicine; Neutropenia; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01179671,0.0001778148,0.001369386,0.00009226481,0.00005638881,0.000005049844,0.0003635481,0.0005338804,0.00009317037],"category_scores_gemma":[0.009263644,0.00009710389,0.0003443316,0.000222214,0.001021124,0.00004137197,0.0001120636,0.001086852,0.000006157571],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000448908,"about_ca_system_score_gemma":0.00175218,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001878189,"about_ca_topic_score_gemma":0.000004906127,"domain_scores_codex":[0.9943777,0.001934765,0.003014516,0.0002815418,0.0001604723,0.000231006],"domain_scores_gemma":[0.992322,0.004711437,0.001851658,0.0002192273,0.0007167722,0.0001788568],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.02761671,0.02028996,0.05150099,0.0001693119,0.002466101,0.00004841666,0.0004813357,0.00006427292,0.4384033,0.0008458793,0.0658879,0.3922258],"study_design_scores_gemma":[0.01427113,0.03335224,0.08576313,0.0003152874,0.001266141,0.00006158311,0.0004841443,0.0006214994,0.7655692,0.001093498,0.09670706,0.0004951331],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9777862,0.0002492144,0.001316044,0.01831611,0.001189638,0.0004607594,0.00001296816,0.000008132555,0.0006609528],"genre_scores_gemma":[0.9547946,0.0000482578,0.0422677,0.002691851,0.0001590175,0.000002929216,0.000002173089,0.000007749079,0.00002574565],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3917307,"threshold_uncertainty_score":0.9990817,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2755435968745606,"score_gpt":0.4906866541260698,"score_spread":0.2151430572515091,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}